Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

ClinicalTrials.gov ID: NCT03455543

Public ClinicalTrials.gov record NCT03455543. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Sham-Controlled, Randomized Trial of Dual Field PEMF Therapy [Provant® Therapy System] in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy (DSPN) (The RELIEF Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Part A of this trial is a multi-center, prospective, double-blinded, sham-controlled, randomized clinical trial. Part A will evaluate PEMF treatment compared to sham treatment in patients with painful diabetic distal symmetric peripheral neuropathy (DSPN) when treatment is administered 30 minutes twice daily through a 120-day period (4 months). Part B is a 8-month open-label active treatment extension period designed to collect longer-term data on pain, medication use, quality of life and safety (Part B).Part B of this trial is a an extension period upon completion of Part A.

Study identification

NCT ID
NCT03455543
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Regenesis Biomedical, Inc.
Industry
Enrollment
182 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2018 (Actual)
Primary completion
Nov 14, 2018 (Actual)
Completion
Jul 18, 2019 (Actual)
Last update posted
Jul 15, 2020

2018 – 2019

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
Physician's Research Group Mesa Arizona 85206 —
Valley Clinical Research Northridge California 91325 —
Northern California Research Sacramento California 95821 —
Diabetes Research Center Tustin California 92780 —
Mountain View Clinical Research Denver Colorado 80209 —
Lake Internal Medicine Associates Eustis Florida 32726 —
Clinical Physiology Associates Fort Myers Florida 33912 —
Spotlight Research Center Miami Florida 33176 —
Clinical Research of Central Florida Winter Haven Florida 33880 —
River Birch Research Alliance, LLC Blue Ridge Georgia 30514 —
MediSphere Medical Research Center, LLC Evansville Indiana 47714 —
Heartland Research Associate, LLC Wichita Kansas 67207 —
Healthcare Research Network Hazelwood Missouri 63042 —
The Center for Pharmaceutical Research, LLC Kansas City Missouri 64114 —
Palm Research Center Las Vegas Nevada 89128 —
Great Lakes Medical Resarch Westfield New York 14787 —
Wake Family Medicine, PC Cary North Carolina 27513 —
Rainier Clinical Research Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03455543, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03455543 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →